GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IVF hartmann Holding AG (XSWX:VBSN) » Definitions » Capex-to-Revenue

IVF hartmann Holding AG (XSWX:VBSN) Capex-to-Revenue : 0.01 (As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is IVF hartmann Holding AG Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

IVF hartmann Holding AG's Capital Expenditure for the six months ended in Jun. 2024 was CHF-0.84 Mil. Its Revenue for the six months ended in Jun. 2024 was CHF76.51 Mil.

Hence, IVF hartmann Holding AG's Capex-to-Revenue for the six months ended in Jun. 2024 was 0.01.


IVF hartmann Holding AG Capex-to-Revenue Historical Data

The historical data trend for IVF hartmann Holding AG's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVF hartmann Holding AG Capex-to-Revenue Chart

IVF hartmann Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.07 0.05 0.02 0.02

IVF hartmann Holding AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.01

Competitive Comparison of IVF hartmann Holding AG's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IVF hartmann Holding AG's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where IVF hartmann Holding AG's Capex-to-Revenue falls into.



IVF hartmann Holding AG Capex-to-Revenue Calculation

IVF hartmann Holding AG's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.42) / 147.953
=0.02

IVF hartmann Holding AG's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.844) / 76.511
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IVF hartmann Holding AG  (XSWX:VBSN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


IVF hartmann Holding AG Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of IVF hartmann Holding AG's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


IVF hartmann Holding AG Business Description

Traded in Other Exchanges
Address
Victor von Bruns Street 28, PO Box 634, Neuhausen, CHE, 8212
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.

IVF hartmann Holding AG Headlines

No Headlines